false
OasisLMS
Hamburger Menu
Catalog
Evolving Trends in Skull Base Tumor Management
Evolving Trends in Skull Base Tumor Management
Description
This Tumor session was recorded live at the 2025 AANS Annual Scientific Meeting.
Adjuvant therapies, such as stereotactic radiosurgery, laser interstitial and targeted systemic treatment, continue to be refined to offer advances in local disease control and overall survival. Participants will learn from debates between leaders in the field and discussions of the future of multidisciplinary skull base tumor treatment.
Speakers: Ahmed Altaf, Carolina Benjamin, Carlos David, Christina Jackson, Debraj Mukherjee, Daniel Prevedello, Adam Robin, Eric Suero Molina, Keki Turel, Alaa Turkistani, Gelareh Zadeh
Accreditation Statement
The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AANS designates this live activity for a maximum of 1.5
AMA PRA Category 1 Credits
™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The last date to claim credit is 06/26/2027.
Disclosure Information
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Education, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.
Those who have disclosed a relationship with ineligible companies are listed below.
All disclosed financial relationships have been mitigated in accordance with ACCME standards.
Name
Relationship/Company
Carlos David
KOGENT: Stock Shareholder (excluding mutual funds) (Ongoing); NextGen Biologics: Stock Shareholder (excluding mutual funds) (Ongoing)
Eric Suero Molina
Carl Zeiss Meditech AG: Grant/Research Support (Ongoing)
Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships or conflict of interest to disclose for this activity.
Summary
Availability:
On-Demand
Release on Jun 26, 2025 12:00 AM Central Daylight Time
Expires on Jun 26, 2027
Cost:
Member: $49.00
Non-Member: $59.00
Resident: $49.00
Credit Offered:
1.5 CME Credits
×
Evolving Trends in Skull Base Tumor Management Course List
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Forgot Password
×
Please select your language
1
English